PharmNet.Bund is the Drug Information Portal of Bund (Federal Government) and Laender (States) and through it an integrated, centralised drug information system develops iteratively.

It provides access to the officially collated data available throughout Germany relating to the marketing authorisation/registration and supervision of medicinal products in Germany.

For Public Access

The information system contains administrative data concerning the authorisation of drugs as well as Summary of Product Characteristics (SPCs) and Patient Information Leaflets (PILs). Furthermore you can find information about:

  • Drug Information System
  • Pharmaceutical Brokers and Wholesaler
  • Clinical Trials

For Companies

Pharmaceutical companies and wholesaler are able to record their data and submit it online to the federal authorities. This includes:

  • Variation Submisson and Approval Exempt
  • Batch Releases
  • Results of Clinical Trials
  • Veterinary Sales

For National Authorities

National authorities are able to research and record national data online. These applications are restricted to staff members of the federal authorities and are only available in German.

Cooperation is a cooperative project of the German regulatory authorities – Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)), the Paul-Ehrlich-Institut (PEI) and the Federal Office of Consumer Protection and Food Safety (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL)) – together with the Robert Koch Institute (RKI) and the German Institute of Medical Documentation and Information (Deutsches Institut für Medizinische Dokumentation und Information (DIMDI)). The project will be implemented in close cooperation with the competent authorities of the Laender coordinated by the Central Authority of the Laender for Health Protection with regard to Medicinal Products and Medical Devices (Zentralstelle der Länder für Gesundheitsschutz bei Arzneimitteln und Medizinprodukten (ZLG)).